O-GlcNAcylation作为胆管癌治疗的新兴分子标 (评论)
Purin Charoensuksai1, Siwanon Jirawatnotai2
1Department of Biomedicine and Health Informatics, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom 73000, Thailand.
Oncology reports
|July 19, 2025
概括
异常的O-GlcNAcylation和O-GlcNAc转移酶 (OGT) 驱动癌症的进展. 准OGT和O-GlcNAc信号显示出治疗胆管癌和其他癌症的前景.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 异常的O-GlcNAcylation和O-GlcNAc转移酶 (OGT) 的上调与癌症病原发生有关.
- 胆管癌 (CCA) 是一种具有攻击性的胆管癌,结果不佳,需要新的治疗策略.
- 在CCA中观察到过度活跃的O-GlcNAcylation和OGT上调.
研究的目的:
- 审查O-GlcNAcylation对CCA和癌症特征的影响.
- 利用其他胃肠道癌症的见解,探索潜在的机械联系.
- 讨论在CCA中准OGT和O-GlcNAcylation的治疗潜力.
主要方法:
- 在癌症中O-GlcNAcylation的文献综述.
- 分析OGT在癌症特征中的作用,如癌症的扩散和转移.
- 从CCA和相关的胃肠道癌症中综合发现.
主要成果:
- O-GlcNAcylation影响癌症的特征,包括扩散,转移,新陈代谢,血管生成,细胞死亡和炎症.
- OGT和O-GlcNAc信号传递是CCA病变发生的关键驱动因素.
- 来自其他癌症的见解为CCA特定机制提供了背景.
结论:
- 准OGT和O-GlcNAc信号传导是胆管癌的可行的治疗策略.
- 需要进一步的研究,以充分阐明O-GlcNAcylation在CCA中的作用.
- O-GlcNAcylation调节为新型癌症疗法提供了一个有希望的途径.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


